However, downregulation of MYPT1 leads to Hippo pathway inactivation, thereby allowing YAP-dependent target gene expression increasing cell proliferation, dedifferentiation to a cancer-stem-cell-like state and resistance to platinum-based therapies (32). Here, YAP1 is linked to cancer.